BIO CEO & Investor Conference 2005
| February 23, 2005 February 24, 2005 | |||
| Webcast Help Link | |||
| Wednesday, February 23, 2005 (All times in EST) | |||
Please Note: Some companies have chosen not to webcast |
|||
| *Please note that there will be a 24 hour delay on Focus Session webcasts. | |||
| Focus Sessions 9:30 - 10:55am | Location | ||
| Biotechnology Company Strategies for Value Creation - How Do They Really Stack Up? | Jade | ||
| Navigating Dramatic Turns in Drug Development | Astor Salon | ||
| Solid progress in combating solid tumors | East Foyer | ||
| Biotech's solutions to Alzheimer's and Parkinson's Disease | Basildon | ||
| Hepatitis: The silent killer | Louis XVI | ||
| Fighting the Enemy Within - Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis and Lupus | Duke of Windsor | ||
| Biomarkers and Drugs: A Happy Marriage? | Conrad Suite | ||
| Personalized Medicine: From Bench to Bedside | Park Ave Suite Center/North | ||
| Company Presentations | Date | Time | Location |
| Alkermes, Inc. | 2/23/2005 | 11:00 AM | Jade |
| Onyx Pharmaceuticals, Inc. | 2/23/2005 | 11:00 AM | Astor Salon |
| AVANT Immunotherapeutics, Inc. | 2/23/2005 | 11:00 AM | Duke of Windsor |
| Geron Corporation | 2/23/2005 | 11:00 AM | East Foyer |
| GTC Biotherapeutics, Inc. | 2/23/2005 | 11:00 AM | Conrad Suite |
| ImmunoGen, Inc. | 2/23/2005 | 11:00 AM | Basildon |
| CytRx Corporation | 2/23/2005 | 11:00 AM | Louis XVI |
| Insmed Incorporated | 2/23/2005 | 11:00 AM | Park Ave. Suite South |
| Raven biotechnologies, inc. | 2/23/2005 | 11:00 AM | Park Ave Suite Center/North |
| AlphaVax, Inc. | 2/23/2005 | 11:30 AM | Park Ave Suite Center/North |
| Hana Biosciences, Inc. | 2/23/2005 | 11:30 AM | Park Ave Suite South |
| CancerVax Corporation | 2/23/2005 | 11:30 AM | Basildon |
| Regeneron Pharmaceuticals, Inc. | 2/23/2005 | 11:30 AM | East Foyer |
| Sequenom, Inc. | 2/23/2005 | 11:30 AM | Conrad Suite |
| Targeted Genetics Corporation | 2/23/2005 | 11:30 AM | Duke of Windsor |
| Tercica, Inc. | 2/23/2005 | 11:30 AM | Louis XVI |
| ZymoGenetics, Inc. | 2/23/2005 | 11:30 AM | Astor Salon |
| Invitrogen Corporation | 2/23/2005 | 11:30 AM | Jade |
| Cell Genesys, Inc. | 2/23/2005 | 12:00 PM | East Foyer |
| Celera Genomics Group | 2/23/2005 | 12:00 PM | Jade |
| Cytokinetics, Inc. | 2/23/2005 | 12:00 PM | Basildon |
| Dyax Corp. | 2/23/2005 | 12:00 PM | Louis XVI |
| SemBioSys Genetics Inc. | 2/23/2005 | 12:00 PM | Conrad Suite |
| MaxCyte, Inc. | 2/23/2005 | 12:00 PM | Park Ave Suite Center/North |
| Metabasis Therapeutics, Inc. | 2/23/2005 | 12:00 PM | Duke of Windsor |
| Vertex Pharmaceuticals Incorporated | 2/23/2005 | 12:00 PM | Astor Salon |
| Corautus Genetics Inc. | 2/23/2005 | 12:00 PM | Park Ave Suite South |
| AEterna Zentaris Inc. | 2/23/2005 | 2:00 PM | Basildon |
| Ligand Pharmaceuticals Incorporated | 2/23/2005 | 2:00 PM | Astor Salon |
| Sangamo BioSciences, Inc. | 2/23/2005 | 2:00 PM | Duke of Windsor |
| Maxim Pharmaceuticals | 2/23/2005 | 2:00 PM | Conrad Suite |
| Genencor International, Inc. | 2/23/2005 | 2:00 PM | Jade |
| Affymax, Inc. | 2/23/2005 | 2:00 PM | Park Ave Suite Center/North |
| InKine Pharmaceutical Company, Inc. | 2/23/2005 | 2:00 PM | Park Ave Suite South |
| Genta Incorporated | 2/23/2005 | 2:00 PM | Louis XVI |
| Sosei Co. Ltd. | 2/23/2005 | 2:00 PM | East Foyer |
| AnorMED Inc. | 2/23/2005 | 2:30 PM | Louis XVI |
| Applied Biosystems Group | 2/23/2005 | 2:30 PM | Jade |
| Avalon Pharmaceuticals, Inc. | 2/23/2005 | 2:30 PM | Park Ave Suite Center/North |
| Juvaris BioTherapeutics, Inc. | 2/23/2005 | 2:30 PM | Park Ave Suite South |
| Lexicon Genetics Incorporated | 2/23/2005 | 2:30 PM | East Foyer |
| Neurogen Corporation | 2/23/2005 | 2:30 PM | Basildon |
| Valentis, Inc. | 2/23/2005 | 2:30 PM | Conrad Suite |
| Vical Inc. | 2/23/2005 | 2:30 PM | Duke of Windsor |
| Adolor Corporation | 2/23/2005 | 2:30 PM | Astor Salon |
| Albany Molecular Research, Inc. | 2/23/2005 | 3:00 PM | East Foyer |
| Alnylam Pharmaceuticals, Inc | 2/23/2005 | 3:00 PM | Duke of Windsor |
| Bayhill Therapeutics, Inc. | 2/23/2005 | 3:00 PM | Park Ave Suite Center/North |
| ChemGenex Pharmaceuticals Ltd. | 2/23/2005 | 3:00 PM | Conrad Suite |
| Critical Therapeutics, Inc. | 2/23/2005 | 3:00 PM | Louis XVI |
| Nektar Therapeutics, Inc. | 2/23/2005 | 3:00 PM | Jade |
| Orchid BioSciences, Inc. | 2/23/2005 | 3:00 PM | Basildon |
| Telik, Inc. | 2/23/2005 | 3:00 PM | Astor Salon |
| MethylGene Inc. | 2/23/2005 | 3:00 PM | Park Ave Suite South |
| Anadys Pharmaceuticals, Inc. | 2/23/2005 | 3:30 PM | Louis XVI |
| OSI Pharmaceuticals | 2/23/2005 | 3:30 PM | Jade |
| Discovery Laboratories, Inc. | 2/23/2005 | 3:30 PM | East Foyer |
| Inhibitex, Inc. | 2/23/2005 | 3:30 PM | Duke of Windsor |
| Nabi Biopharmaceuticals | 2/23/2005 | 3:30 PM | Astor Salon |
| Senomyx, Inc. | 2/23/2005 | 3:30 PM | Basildon |
| Alteon Inc. | 2/23/2005 | 3:30 PM | Conrad Suite |
| Structural GenomiX, Inc. | 2/23/2005 | 3:30 PM | Park Ave Suite Center/North |
| Focus Sessions 4:00 - 5:25pm | Location | ||
| Beyond the IPO: Follow-on Financing Trends | Jade | ||
| Getting from A to Z: Is the Shortest Distance to Commercialization a Straight Line? | Astor Salon | ||
| The Next Wave of Targeted Therapies for Treating Cancer | East Foyer | ||
| A heart to heart discussion on future Cardiovascular therapies | Basildon | ||
| Cure the pain - reap the (overlooked) gain | Louis XVI | ||
| HIV: The war against resistance | Duke of Windsor | ||
| Gene Therapy: Are we there yet? Are we there yet? | Conrad Suite | ||
| Drup Development: Finding gold in other drugs | Park Ave Suite Center/North | ||